Cost‐Effectiveness of Therapeutic Drug Monitoring in Diagnosing Primary Aldosteronism in Patients With Resistant Hypertension

Primary aldosteronism (PA) is present in up to 20% of patients with treatment‐resistant hypertension (TRH). Investigation for PA in patients with TRH is recommended by current guidelines after medication nonadherence is excluded. Studies using therapeutic drug monitoring (TDM) have shown that >50...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Clin Hypertens (Greenwich)
Auteurs principaux: Velasco, Alejandro, Chung, Oliver, Raza, Fayez, Pandey, Ambarish, Brinker, Stephanie, Arbique, Debbie, Price, Angela, Lotan, Yair, Das, Sandeep R., Vongpatanasin, Wanpen
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2015
Sujets:
Original Papers
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4562815/
https://ncbi.nlm.nih.gov/pubmed/25917401
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jch.12570
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires